Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-07
2000-03-28
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 63, 514100, 549214, 549216, 549267, A61K 31365, C07D49327
Patent
active
060432705
ABSTRACT:
Compounds having anti-inflammatory and other activities are disclosed. The compounds are derived from phorboids of the polyacetate-, diaminobenzyl alcohol-, diacylglycerol- and bryostatin-classes.
REFERENCES:
patent: 4376821 (1983-03-01), Braude
patent: 4376822 (1983-03-01), Braude
patent: 4401756 (1983-08-01), Gillis
patent: 4460685 (1984-07-01), Vilcek et al
patent: 4560774 (1985-12-01), Pettit et al.
patent: 4716179 (1987-12-01), Hecker et al.
patent: 5154842 (1992-10-01), Driedger et al.
patent: 5643948 (1997-07-01), Driedger et al.
patent: 5716968 (1998-02-01), Driedger et al.
patent: 5750568 (1998-05-01), Driedger et al.
Driedger, Chem. Abstract 109:128719 for WO 87/07599 (Dec. 17, 1987).
Jeffrey, A. and Liskamp, R., "Computer-Assisted Molecular Modeling of Tumor Promoters: Rationale for the Activity of Phorbol Esters, Teleocidin B, and Aplysiatoxin," Proc. Natl. Acad. Sci. USA 83: 241-245 (Jan. 1986).
Sugimura, T., "Potent Tumor Promoters Other Than Phorbol Ester and Their Significance," Gann 73(4): 499-507 (Aug. 1982).
Nishizuka, Y., "The Role of Protein Kinase C in Cell Surface Signal Transduction and Tumour Promotion," Nature 308: 693-698 (Apr. 19, 1984).
Ganong, B., et al., "Specificity and Mechanism of Protein Kinase C Activation by sn-1,2-diacylglycerols," Proc. Natl. Acad. Sci. USA 83: 1184-1188 (Mar. 1986).
Schmidt, R. and Hecker, E., "Simple Phorbol Esters as Inhibitors of Tumor Promotion by TPA in Mouse Skin," Carcinogenesis 7 : 57-63 (1982).
Wender, P. et al., "Analysis of the Phorbol Ester Pharmacophore on Protein Kinase C as a Guide to the Rational design of New Classes of Analogs," Proc. Natl. Acad. Sci. USA 83: 4214-4218 (Jun. 1986).
Driedger Paul E.
Quick James
Procyon Pharmaceuticals, Inc.
Raymond Richard L.
LandOfFree
Protein kinase C modulators V does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protein kinase C modulators V, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein kinase C modulators V will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1326409